OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Computational approaches streamlining drug discovery
Anastasiia Sadybekov, Vsevolod Katritch
Nature (2023) Vol. 616, Iss. 7958, pp. 673-685
Open Access | Times Cited: 541

Boosting Protein–Ligand Binding Pose Prediction and Virtual Screening Based on Residue–Atom Distance Likelihood Potential and Graph Transformer
Chao Shen, Xujun Zhang, Yafeng Deng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 15, pp. 10691-10706
Closed Access | Times Cited: 112

Artificial Intelligence in Pharmaceutical Sciences
Mingkun Lu, Jiayi Yin, Qi Zhu, et al.
Engineering (2023) Vol. 27, pp. 37-69
Open Access | Times Cited: 64

Structure-based discovery of conformationally selective inhibitors of the serotonin transporter
Isha Singh, Anubha Seth, Christian B. Billesbølle, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2160-2175.e17
Open Access | Times Cited: 45

Computational drug development for membrane protein targets
Haijian Li, Xiaolin Sun, Wenqiang Cui, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 229-242
Closed Access | Times Cited: 16

Integrating structure-based approaches in generative molecular design
Morgan Thomas, Andreas Bender, Chris de Graaf
Current Opinion in Structural Biology (2023) Vol. 79, pp. 102559-102559
Open Access | Times Cited: 39

A generalized protein–ligand scoring framework with balanced scoring, docking, ranking and screening powers
Chao Shen, Xujun Zhang, Chang‐Yu Hsieh, et al.
Chemical Science (2023) Vol. 14, Iss. 30, pp. 8129-8146
Open Access | Times Cited: 34

The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery
Hiroshi Komura, Reiko Watanabe, Kenji Mizuguchi
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2619-2619
Open Access | Times Cited: 29

Molecular Docking and Molecular Dynamics Simulations in Related to Leishmania donovani: An Update and Literature Review
Mabel R. Challapa-Mamani, Eduardo Tomás-Alvarado, Angela Espinoza-Baigorria, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 10, pp. 457-457
Open Access | Times Cited: 23

Structure-based virtual screening of vast chemical space as a starting point for drug discovery
Jens Carlsson, Andreas Luttens
Current Opinion in Structural Biology (2024) Vol. 87, pp. 102829-102829
Open Access | Times Cited: 14

Flexible scaffold-based cheminformatics approach for polypharmacological drug design
Zhangcheng Chen, Jing Yu, Huan Wang, et al.
Cell (2024) Vol. 187, Iss. 9, pp. 2194-2208.e22
Closed Access | Times Cited: 11

Orphan G protein-coupled receptors: the ongoing search for a home
Amie Jobe, Ranjit Vijayan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10

Understanding the molecular mechanisms of odorant binding and activation of the human OR52 family
Chulwon Choi, Jungnam Bae, Seonghan Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1
Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo, et al.
Science Advances (2024) Vol. 10, Iss. 32
Open Access | Times Cited: 7

Molecular Pharmacology of P2X Receptors: Exploring Druggable Domains Revealed by Structural Biology
Adam Oken, Ipsita Krishnamurthy, Jonathan C. Savage, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24

Modeling the Orthosteric Binding Site of the G Protein-Coupled Odorant Receptor OR5K1
Alessandro Nicoli, Franziska Haag, Patrick Marcinek, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 7, pp. 2014-2029
Open Access | Times Cited: 15

What are the current trends in G protein-coupled receptor targeted drug discovery?
Vicent Casadó, Verònica Casadó-Anguera
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 815-820
Open Access | Times Cited: 15

CarsiDock: a deep learning paradigm for accurate protein–ligand docking and screening based on large-scale pre-training
Heng Cai, Chao Shen, Tianye Jian, et al.
Chemical Science (2023) Vol. 15, Iss. 4, pp. 1449-1471
Open Access | Times Cited: 15

The chronological evolution of fluorescent GPCR probes for bioimaging
Yingxu Wu, Boyu Zhang, Hu Xu, et al.
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215040-215040
Closed Access | Times Cited: 13

Machine learning-aided search for ligands of P2Y6 and other P2Y receptors
Ana C. Puhl, Sarah A. Lewicki, Zhan‐Guo Gao, et al.
Purinergic Signalling (2024)
Open Access | Times Cited: 5

Improving the Reliability of Language Model-Predicted Structures as Docking Targets through Geometric Graph Learning
Chao Shen, Xiaoqi Han, Heng Cai, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Molecular simulations guided drugs repurposing to inhibit human GPx1 enzyme for cancer therapy
Muhammad Waleed Iqbal, Syed Zeeshan Haider, Muhammad Zohaib Nawaz, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108279-108279
Closed Access

Molecular docking technology drives multidimensional applications of microbial natural products
Chan Zhang, Qingjie Sun, Arzugul Ablimit, et al.
Journal of Molecular Structure (2025), pp. 142044-142044
Closed Access

Page 1 - Next Page

Scroll to top